What are the benefits of pegylated IFN-a 2a (PEG-IFN-a 2a) in the treatment of hepatitis B (HBV) (Hep B)?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

PEG-IFN-a 2a has an enhanced half-life relative to the standard INF-a. Pegylation lowers the rate of absorption following subcutaneous (SC) injection, reduces renal clearance, and decreases the immunogenicity of the interferon.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!